Trial Profile
A Phase I Study of Methoxyamine Combined With Chemo-Radiation for Locally Advanced Non-Squamous Non-Small Cell Lung Cancer
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 04 Jul 2022
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Pemetrexed (Primary) ; TRC 102 (Primary) ; Ropidoxuridine
- Indications Adenocarcinoma; Large cell carcinoma; Non-small cell lung cancer
- Focus Adverse reactions
- 29 Jun 2022 Status changed from active, no longer recruiting to completed.
- 05 Nov 2021 Results published in the Clinical Cancer Research
- 31 May 2020 Results evaluating safety of PEM-TRC102 combined with cisplatin/radiotherapy in non-squamous NSCLC, presented at the 56th Annual Meeting of the American Society of Clinical Oncology